RecruitingNot ApplicableNCT07415668

Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning


Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

30 participants

Start Date

May 8, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

With this project, the study group wants to investigate whether a postoperative navigated transcranial magnetic stimulation (nTMS) motor map can improve stereotactic radiosurgery (SRS) planning in patients who underwent resection for a brain metastasis near the primary motor cortex. Specifically, the map could allow for more precise location of motor eloquent tissue, thereby minimizing the radiation dose on these areas while preserving high radiation dose on target tissue (i.e. tumor cells).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Navigated Transcranial Magnetic Stimulation (nTMS) for people with metastases to brain. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENavigated Transcranial Magnetic Stimulation (nTMS)

Every patient will undergo a postoperative nTMS motor mapping, and both the "standard" and "nTMS-adapted" SRS plan will be created for every patient. The plan will be selected by the radiation oncologist, depending on whether at least 95% of the dose is administered to the target volume with the "nTMS-adapted" plan or not. Every patient then receives SRS.


Locations(1)

University Hostpital Bern, Department of Neurosurgery Bern

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07415668


Related Trials